Synthroid · DIN 02172089 · 0.075 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Synthroid · DIN 02172089
Manufacturer: Abbott Laboratories Limited; listing date 1996-10-01
Health Canada: Marketed since 2016-03-10 · brand SYNTHROID · ATC H03AA01 LEVOTHYROXINE SODIUM · form Tablet · route Oral · ingredients LEVOTHYROXINE SODIUM 75 MCG · company Bgp pharma ulc · schedule Prescription
Ministry pays: $0.0646 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02172089)
Source record
DIN 02172089: Synthroid
Raw flags: sec3=Y
Item: 683600017; group id 805; item number 1972; lccId None; manufacturer id ABB
Source form: Tab; strength: 0.075mg
Recorded listing: General benefit
Source prices (unrounded): $0.1247; ministry $0.0646
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02172089
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19595
Interchangeable products
Apo-Levothyroxine · DIN 02550725 · $0.0646
Shortage status: not checked (no credentials)